.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Covington
Healthtrust
UBS
Harvard Business School
Cerilliant
Dow
McKinsey
Colorcon

Generated: February 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Denmark Patent: 2007 00783

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-001Jul 10, 2015RXYesNo➤ Sign Up➤ Sign UpPROPHYLAXIS OF ORGAN REJECTION
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-002Jul 10, 2015RXYesNo➤ Sign Up➤ Sign UpPROPHYLAXIS OF ORGAN REJECTION
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-003Jul 10, 2015RXYesYes➤ Sign Up➤ Sign UpPROPHYLAXIS OF ORGAN REJECTION
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-001Jul 10, 2015RXYesNo➤ Sign Up➤ Sign UpYPROPHYLAXIS OF ORGAN REJECTION
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-002Jul 10, 2015RXYesNo➤ Sign Up➤ Sign UpYPROPHYLAXIS OF ORGAN REJECTION
Veloxis Pharms IncENVARSUS XRtacrolimusTABLET, EXTENDED RELEASE;ORAL206406-003Jul 10, 2015RXYesYes➤ Sign Up➤ Sign UpYPROPHYLAXIS OF ORGAN REJECTION
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist